Zenas BioPharma (ZBIO) Assets Average (2024 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Assets Average of $565.7 million for Q1 2026, up 60.76% year-over-year from $351.9 million in Q1 2025, and up 60.32% quarter-over-quarter from $352.8 million in Q4 2025.
Zenas BioPharma (ZBIO) Assets Average (2024 - 2026) Analysis & Trends
Zenas BioPharma's Assets Average history runs 3 years deep, the most recent figure standing at $565.7 million for Q1 2026.
- In Q1 2026, Assets Average rose 60.76% year-over-year to $565.7 million; the TTM figure through Mar 2026 stood at $565.7 million (up 60.76% YoY), while the FY2025 annual figure was $376.8 million, up 72.0% from the prior year.
- Assets Average for Q1 2026 stood at $565.7 million, up from $352.8 million in the prior quarter.
- The five-year high for Assets Average was $565.7 million in Q1 2026, with the low at $307.6 million in Q3 2025.
- The 3-year median for Assets Average is $352.3 million (2025), against an average of $379.7 million.
- The sharpest annual moves came in 2025 and 2026: Assets Average dropped 8.76% in 2025, then soared 60.76% in 2026.
- Zenas BioPharma's Assets Average stood at $386.7 million in 2024, then decreased by 8.76% to $352.8 million in 2025, then jumped by 60.32% to $565.7 million in 2026.
- Business Quant data shows ZBIO's Assets Average at $565.7 million in Q1 2026, $352.8 million in Q4 2025, and $307.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | 724.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 724.69 Mn |
| Mar 31, 2026 | 565.66 Mn |
| Dec 31, 2025 | 352.83 Mn |
| Sep 30, 2025 | 307.55 Mn |
| Jun 30, 2025 | 313.43 Mn |
| Mar 31, 2025 | 351.87 Mn |
| Dec 31, 2024 | 386.70 Mn |